Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$112.19
Price-0.97%
-$1.10
1Y
Price
Market Cap
$195.262b
Large
Price/Earnings 3y Avg5y Avg
30.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+22.0%
EBITDA Margin+15.5%
Net Profit Margin+20.0%
Free Cash Flow Margin+22.0%
EBITDA Margin+15.5%
Net Profit Margin+20.0%
Free Cash Flow MarginRevenue
$44.328b
+5.7%
1y CAGR+0.7%
3y CAGR+0.9%
5y CAGREarnings
$6.524b
-51.3%
1y CAGR+21.8%
3y CAGR+15.9%
5y CAGREPS
$3.72
-51.2%
1y CAGR+22.0%
3y CAGR+16.3%
5y CAGRBook Value
$47.901b
$81.414b
Assets$33.513b
Liabilities$15.275b
DebtDebt to Assets
18.8%
1.1x
Debt to EBITDAFree Cash Flow
$6.351b
+36.7%
1y CAGR-2.7%
3y CAGR+10.7%
5y CAGRNo items found.
Press Releases
Statements and updates from the company